Gender differences in response to an opportunistic brief intervention for obesity in primary care: Data from the BWeL trial.

brief opportunistic intervention gender primary care randomized controlled trial weight loss

Journal

Clinical obesity
ISSN: 1758-8111
Titre abrégé: Clin Obes
Pays: England
ID NLM: 101560587

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 10 06 2020
revised: 11 08 2020
accepted: 02 09 2020
pubmed: 8 10 2020
medline: 26 10 2021
entrez: 7 10 2020
Statut: ppublish

Résumé

Weight loss programmes appeal mainly to women, prompting calls for gender-specific programmes. In the United Kingdom, general practitioners (GPs) refer nine times as many women as men to community weight loss programmes. GPs endorsement and offering programmes systematically could reduce this imbalance. In this trial, consecutively attending patients in primary care with obesity were invited and 1882 were enrolled and randomized to one of two opportunistic 30-second interventions to support weight loss given by GPs in consultations unrelated to weight. In the support arm, clinicians endorsed and offered referral to a weight loss programme and, in the advice arm, advised that weight loss would improve health. Generalized linear mixed effects models examined whether gender moderated the intervention. Men took effective weight loss action less often in both arms (support: 41.6% vs 60.7%; advice: 12.1% vs 18.3%; odds ratio (OR) = 0.38, 95% confidence interval (CI), 0.27, 0.52, P < .001) but there was no evidence that the relative effect differed by gender (interaction P = .32). In the support arm, men accepted referral and attended referral less often, 69.3% vs 82.4%; OR = 0.48, 95% CI, 0.35, 0.66, P < .001 and 30.4% vs 47.6%; OR = 0.48, 95% CI, 0.36, 0.63, P < .001, respectively. Nevertheless, the gender balance in attending weight loss programmes closed to 1.6:1. Men and women attended the same number of sessions (9.7 vs 9.1 sessions, P = .16) and there was no evidence weight loss differed by gender (6.05 kg men vs 4.37 kg women, P = .39). Clinician-delivered opportunistic 30-second interventions benefits men and women equally and reduce most of the gender imbalance in attending weight loss programmes.

Identifiants

pubmed: 33026192
doi: 10.1111/cob.12418
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12418

Subventions

Organisme : NIHR Oxford Biomedical Research Centre and CLAHRC Oxford
Organisme : NIHR Oxford Biomedical Research Centre
Organisme : Medical Research Council
ID : MR/J000515/1
Pays : United Kingdom

Informations de copyright

© 2020 The Authors. Clinical Obesity published by John Wiley & Sons Ltd on behalf of World Obesity Federation.

Références

Digital N. Health Survey for England 2017. Adult and Child Overweight and Obesity, 2018.
Piernas C, Aveyard P, Jebb SA. Recent trends in weight loss attempts: repeated cross-sectional analyses from the health survey for England. Int J Obes (Lond). 2016;40(11):1754-1759. https://doi.org/10.1038/ijo.2016.141.
Stubbs RJ, Morris L, Pallister C, Horgan G, Lavin JH. Weight outcomes audit in 1.3 million adults during their first 3 months' attendance in a commercial weight management programme. BMC Public Health. 2015;15:882. https://doi.org/10.1186/s12889-015-2225-0.
Stubbs RJ, Pallister C, Whybrow S, Avery A, Lavin J. Weight outcomes audit for 34,271 adults referred to a primary care/commercial weight management partnership scheme. Obes Facts. 2011;4(2):113-120. https://doi.org/10.1159/000327249.
Robertson C, Archibald D, Avenell A, et al. Systematic reviews of and integrated report on the quantitative, qualitative and economic evidence base for the management of obesity in men. Health Technol Assess. 2014;18(35):1-424. https://doi.org/10.3310/hta18350 v-vi, xxiii-xxix.
Moyer VA, Force USPST. Screening for and management of obesity in adults: U.S. preventive services task force recommendation statement. Ann Intern Med. 2012;157(5):373-378. https://doi.org/10.7326/0003-4819-157-5-201209040-00475.
Booth HP, Prevost AT, Gulliford MC. Access to weight reduction interventions for overweight and obese patients in UKprimary care: population-based cohort study. BMJ Open. 2015;5(1):e006642. https://doi.org/10.1136/bmjopen-2014-006642.
Ells L, Watson P, Carlebach S, et al. A mixed method evaluation of adult tier 2 lifestyle weight management service provision across a county in northern England. Clin Obes. 2018;8(3):191-202. https://doi.org/10.1111/cob.12250.
Pagoto SL, Schneider KL, Oleski JL, Luciani JM, Bodenlos JS, Whited MC. Male inclusion in randomized controlled trials of lifestyle weight loss interventions. Obesity. 2012;20(6):1234-1239.
Ahern AL, Aveyard P, Boyland EJ, Halford JC, Jebb SA. Team wt. inequalities in the uptake of weight management interventions in a pragmatic trial: an observational study in primary care. Br J Gen Pract. 2016;66(645):e258-e263. https://doi.org/10.3399/bjgp16X684337.
Hunt K, Wyke S, Gray CM, et al. A gender-sensitised weight loss and healthy living programme for overweight and obese men delivered by Scottish premier league football clubs (FFIT): a pragmatic randomised controlled trial. Lancet. 2014;383(9924):1211-1221. https://doi.org/10.1016/S0140-6736(13)62420-4.
Jebb SA, Ahern AL, Olson AD, et al. Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial. Lancet. 2011;378(9801):1485-1492. https://doi.org/10.1016/S0140-6736(11)61344-5.
Jolly K, Lewis A, Beach J, et al. Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: lighten up randomised controlled trial. BMJ. 2011;343:d6500. https://doi.org/10.1136/bmj.d6500.
Madigan CD, Daley AJ, Lewis AL, Jolly K, Aveyard P. Which weight-loss programmes are as effective as weight watchers(R)?: non-inferiority analysis. Br J Gen Pract. 2014;64(620):e128-e136. https://doi.org/10.3399/bjgp14X677491.
Ahern AL, Wheeler GM, Aveyard P, et al. Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial. Lancet. 2017;389(10085):2214-2225. https://doi.org/10.1016/S0140-6736(17)30647-5.
Ahern AL, Olson AD, Aston LM, Jebb SA. Weight watchers on prescription: an observational study of weight change among adults referred to weight watchers by the NHS. BMC Public Health. 2011;11:434. https://doi.org/10.1186/1471-2458-11-434.
Lewis A, Jolly K, Adab P, et al. A brief intervention for weight management in primary care: study protocol for a randomized controlled trial. Trials. 2013;14:393. https://doi.org/10.1186/1745-6215-14-393.
Aveyard P, Lewis A, Tearne S, et al. Screening and brief intervention for obesity in primary care: a parallel, two-arm, randomised trial. Lancet. 2016;388(10059):2492-2500. https://doi.org/10.1016/S0140-6736(16)31893-1.
Tillin T, Sattar N, Godsland IF, Hughes AD, Chaturvedi N, Forouhi NG. Ethnicity-specific obesity cut-points in the development of type 2 diabetes-a prospective study including three ethnic groups in the United Kingdom. Diabet Med. 2015;32(2):226-234. https://doi.org/10.1111/dme.12576.
Elobeid MA, Padilla MA, McVie T, et al. Missing data in randomized clinical trials for weight loss: scope of the problem, state of the field and performance of statistical methods. PLoS One. 2009;4(8):e6624. https://doi.org/10.1371/journal.pone.0006624.
Sabinsky MS, Toft U, Raben A, Holm L. Overweight men's motivations and perceived barriers towards weight loss. Eur J Clin Nutr. 2007;61(4):526-531. https://doi.org/10.1038/sj.ejcn.1602537.
Archibald D, Douglas F, Hoddinott P, et al. A qualitative evidence synthesis on the management of male obesity. BMJ Open. 2015;5(10):e008372. https://doi.org/10.1136/bmjopen-2015-008372.
Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association task Force on practice guidelines and the Obesity Society. J Am Coll Cardiol. 2014;63(25, pt B):2985-3023. https://doi.org/10.1016/j.jacc.2013.11.004.
Excellence NIfHaC. Obesity: identification, assessment and management, 2014.
Brauer P, Gorber SC, Shaw E, et al. Recommendations for prevention of weight gain and use of behavioural and pharmacologic interventions to manage overweight and obesity in adults in primary care. CMAJ. 2015;187(3):184-195. https://doi.org/10.1503/cmaj.140887.
Noordman J, Verhaak P, van Dulmen S. Discussing patient's lifestyle choices in the consulting room: analysis of GP-patient consultations between 1975 and 2008. BMC Fam Pract. 2010;11(87). https://doi.org/10.1186/1471-2296-11-87.
Shiffman S, Sweeney CT, Pillitteri JL, Sembower MA, Harkins AM, Wadden TA. Weight management advice: what do doctors recommend to their patients? Prev Med. 2009;49(6):482-486. https://doi.org/10.1016/j.ypmed.2009.09.015.
Mercer SW, Tessier S. A qualitative study of general practitioners' and practice nurses' attitudes to obesity management in primary care. Health Bull (Edinb). 2001;59(4):248-253.
A systematic review and thematic synthesis of qualitative studies exploring GP and nurses' perspectives on discussing weight with patients with overweight and obesity in primary care. NIHR Oxford Biomedical Research Centre: Chronic diseases cluster and theme networking event.; University of Oxford, 2019.

Auteurs

Kate Tudor (K)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
NIHR Oxford Biomedical Research Centre, Oxford University Hospitals, Oxford, UK.

Sarah Tearne (S)

Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

Susan A Jebb (SA)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
NIHR Oxford Biomedical Research Centre, Oxford University Hospitals, Oxford, UK.

Amanda Lewis (A)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Peymane Adab (P)

Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

Rachna Begh (R)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Kate Jolly (K)

Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

Amanda Daley (A)

School of Sport, Exercise, and Health Sciences, Loughborough University, Loughborough, UK.

Amanda Farley (A)

Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

Deborah Lycett (D)

Faculty Research Centre for Advances in Behavioural Science, Coventry University, Coventry, UK.

Alecia Nickless (A)

School of Chemistry, University of Bristol, Bristol, UK.

Paul Aveyard (P)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
NIHR Oxford Biomedical Research Centre, Oxford University Hospitals, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH